Your browser doesn't support javascript.
loading
Corrigendum to "SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway" [Neoplasia (2021) 23, 1037-1047].
Luo, Zhenzhen; Wang, Jing; Zhu, Yue; Sun, Xiao; He, Chenchen; Cai, Mengjiao; Ma, Jinlu; Wang, Yi; Han, Suxia.
Affiliation
  • Luo Z; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang J; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhu Y; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Sun X; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • He C; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Cai M; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Ma J; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang Y; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China. Electronic address: 18210912568@163.com.
  • Han S; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: shan87@mail.xjtu.edu.cn.
Neoplasia ; 55: 101011, 2024 Sep.
Article in En | MEDLINE | ID: mdl-39009486

Full text: 1 Database: MEDLINE Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: China